****************************************************************** ** This file contains an ASCII representation of the text of a ** ** GAO report. Delineations within the text indicating chapter ** ** titles, headings, and bullets are preserved. Major ** ** divisions and subdivisions of the text, such as Chapters, ** ** Sections, and Appendixes, are identified by double and ** ** single lines. The numbers on the right end of these lines ** ** indicate the position of each of the subsections in the ** ** document outline. These numbers do NOT correspond with the ** ** page numbers of the printed product. ** ** ** ** No attempt has been made to display graphic images, although ** ** figure captions are reproduced. Tables are included, but ** ** may not resemble those in the printed version. ** ** ** ** Please see the PDF (Portable Document Format) file, when ** ** available, for a complete electronic file of the printed ** ** document's contents. ** ** ** ** A printed copy of this report may be obtained from the GAO ** ** Document Distribution Center. For further details, please ** ** send an e-mail message to: ** ** ** ** ** ** ** ** with the message 'info' in the body. ** ****************************************************************** Cover ================================================================ COVER Report to Congressional Requesters September 1998 DOD COUNTERDRUG ACTIVITIES - REPORTED COSTS DO NOT REFLECT EXTENT OF DOD'S SUPPORT GAO/NSIAD-98-231 Counterdrug Activities (701131) Abbreviations =============================================================== ABBREV DOD - Department of Defense O&S - operating and support OPTEMPO - Central Transfer Account and the military services' operations VAMOSC - Visibility and Management of Operating and Support Costs Letter =============================================================== LETTER B-279766 September 23, 1998 The Honorable James M. Inhofe Chairman The Honorable Charles S. Robb Ranking Minority Member Subcommittee on Military Readiness Committee on Armed Services United States Senate The Department of Defense (DOD) provides personnel, equipment, and facilities in support of U.S. drug interdiction and other counterdrug activities. The Office of National Drug Control Policy reported that DOD's fiscal year 1999 budget request for these activities is $882.8 million. Because you believe the reported funds do not reflect the full extent of DOD's support, you asked us to determine, for fiscal years 1994 through 1998 (1) the total operating and support (O&S) costs that can be associated with counterdrug activities and (2) the share of the original procurement costs of those weapon systems most often used by the active component in counterdrug activities.\1 Under the Foreign Assistance Act, DOD also provides assistance to foreign countries in support of counterdrug activities. You asked us to determine, for fiscal years 1994 through 1998, the amount of assistance DOD provided under section 506(a)(2)(A)(i)(I) of the act, hereafter referred to as 506(a)(2). -------------------- \1 O&S costs are those resources required to operate and support a system, a subsystem, or a major component during its useful life in the operational inventory. BACKGROUND ------------------------------------------------------------ Letter :1 The U.S. response to drug abuse and drug trafficking is to integrate domestic and international efforts to reduce the demand and supply of drugs. The Office of National Drug Control Policy was established by the Anti-Drug Abuse Act of 1988. It is responsible for establishing policies, priorities, and objectives for the nation's drug control program. The Office has established five long-range goals as a basis to reduce drug abuse, trafficking, and their consequences. DOD supports each of these goals, as shown in table 1. Table 1 National Drug Control Strategy Goals and DOD's Support Goal Description Examples of DOD's efforts ---- ------------------------------- ------------------------------- 1 Educate and enable America's National Guard and service youth to reject illegal drugs outreach programs (primarily as well as alcohol and tobacco for youths) that assist community groups. 2 Increase the safety of DOD components provide direct America's citizens by support to drug law enforcement substantially reducing drug- agencies in the form of related crime and violence equipment and support services. 3 Reduce health and social costs DOD provides demand reduction, to the public of illegal drug drug testing, education, and use awareness programs for uniformed and civilian employees. 4 Shield America's air, land, and DOD provides personnel and sea frontiers from the drug equipment to detect and monitor threat drug trafficking to the United States. 5 Break foreign and domestic drug DOD supports intelligence, sources of supply detection, monitoring, and interdiction efforts in foreign countries. ---------------------------------------------------------------------- Source: The National Drug Control Strategy, 1998: Budget Summary and Ten-Year Plan. DOD's counterdrug budget, as reported by the Office, is comprised of two major categories: the Central Transfer Account and the military departments' operations (OPTEMPO). The Office defines the Central Transfer Account as a single budget line that accounts for all associated DOD counterdrug resources, with the exception of active component military personnel costs and military OPTEMPO. Specifically, the account funds such items as special supply and equipment purchases, reserve component military personnel costs, and travel costs for individuals supporting counterdrug activities. The military departments' OPTEMPO costs, currently funded in the services' operation and maintenance accounts, are for fuel, spare parts, and depot-level repairables for weapon systems used in counterdrug activities. Table 2 shows DOD's reported counterdrug spending for fiscal years 1994-98. Table 2 DOD's Reported Counterdrug Spending for Fiscal Years 1994-98 (Dollars in millions) Fiscal year ---------------------------------- 1998\ Category 1994 1995 1996 1997 a Total -------------------------- ------ ----- ----- ----- ----- ====== Central Transfer Account $671.3 $721. $678. $806. $712. $3,590 3 4 2 9 .1 Military OPTEMPO 143.6 118.9 143.6 133.8 134.9 674.8 ====================================================================== Total $814.9 $840. $822. $940. $847. $4,264 2 1 1 7 .9 ---------------------------------------------------------------------- Note: Totals do not add due to rounding. \a Enacted budget authority for fiscal year 1998. Source: Office of National Drug Control Policy's budget summaries for 1995-98. DOD provides assistance to foreign countries that support counterdrug activities. An authority to transfer defense equipment and services to support international narcotics control efforts is section 506(a)(2) of the Foreign Assistance Act. RESULTS IN BRIEF ------------------------------------------------------------ Letter :2 There are significant operating and support costs for counterdrug activities that are not reflected in DOD's counterdrug reported costs and funding requests. These include costs associated with military services' weapon systems and costs for deployed personnel who are not assigned to specific weapon systems. The costs associated with weapon systems, if allocated to counterdrug activities, would total in excess of $2 billion for fiscal years 1994 through 1996.\2 The number of military personnel deployed in the United States who were not assigned to specific weapon systems totaled about 14,000. These individuals were assigned for various time periods between fiscal year 1994 and 1996. Although we did not estimate the support costs for these personnel, they would be in addition to the costs reported by DOD and the $2 billion we estimated. According to DOD officials, these operating and support costs are not included in DOD's counterdrug budgets because they pertain to the existing force structure that supports the national defense mission and would be incurred regardless of the type of operations conducted. This practice is consistent with the way DOD reports incremental costs for contingency operations. The military services use numerous weapon systems for counterdrug activities that were purchased to support the national military strategy. The weapon systems most often used for counterdrug activities were the Air Force's E-3 aircraft, the Army's UH-60 helicopter, and the Navy's P-3 aircraft and Perry class frigate. With the assistance of service officials, we developed a methodology to allocate to counterdrug activities a share of the original procurement costs of these systems. Using this methodology, we calculated that about $150 million of the procurement costs for these four systems could be allocated to counterdrug activities for fiscal years 1994-97.\3 In fiscal years 1994 and 1995, there were no transfers of articles and services to foreign countries under section 506(a)(2). In fiscal years 1996 and 1997,\4 a total of $131 million in articles and services were transferred from DOD under this authority. -------------------- \2 Cost data were not yet available for fiscal years 1997 and 1998. \3 Data were not yet available to estimate these costs for fiscal year 1998. \4 As of August 14, 1998, there had been no approved transfers of equipment and services under this section for fiscal year 1998. ADDITIONAL O&S COSTS ASSOCIATED WITH DOD'S COUNTERDRUG ACTIVITIES ------------------------------------------------------------ Letter :3 There are significant O&S costs associated with the military services' weapon systems used for counterdrug activities that are not reflected in DOD's counterdrug reported costs and funding requests. These include intermediate and depot-level maintenance costs, active military personnel salaries and benefits, and base operating support costs. To identify these additional costs, we primarily used the services' Visibility and Management of Operating and Support Costs (VAMOSC) database,\5 which allocates O&S costs by weapon system. We determined that there were O&S costs for major weapon systems (ships and aircraft) used in counterdrug activities in excess of $2 billion over the $406.2 million in OPTEMPO costs reported by DOD for fiscal years 1994 through 1996.\6 Figure 1 compares these additional costs to DOD's reported costs by fiscal year. Figure 1: Additional O&S Costs and DOD's Reported OPTEMPO Costs for Counterdrug Activities (See figure in printed edition.) Note: Totals do not add due to rounding. Source: Developed by GAO using DOD and service data. Our estimate incorporated all O&S costs for these systems reported in the VAMOSC database. However, each service reports O&S data differently. To the extent possible, we obtained additional data from other service sources to develop comparable costs across the services and added the additional costs to the VAMOSC data. For example, because Navy installation support costs are not captured in its VAMOSC database, we calculated these costs based on average cost factors and personnel data provided by the Navy. We were unable to obtain the same categories of data for the services in all cases. In addition to O&S costs associated with weapon systems, there were support costs associated with personnel deployed for counterdrug activities who were not assigned to specific weapon systems, such as personnel in intelligence units. For example, about 14,000 military personnel were assigned to counterdrug activities in the United States between fiscal year 1994 and 1996 who were not associated with specific weapon systems. During those years, these personnel were assigned to missions for varying lengths of time on a rotational basis. The pay, benefits, and support costs associated with these personnel were in addition to the counterdrug costs reported by DOD and the $2 billion we estimated.\7 DOD officials indicated that these additional O&S costs are not included in DOD's counterdrug budget because they pertain to the existing force structure that supports the national defense mission and, therefore, they would be incurred regardless of the type of operations conducted. This practice is consistent with the way DOD reports incremental costs for contingency operations. -------------------- \5 An information system for reporting historical weapon system O&S costs derived from a wide range of service data sources. \6 VAMOSC data were not yet available for fiscal years 1997 and 1998. \7 We did not estimate a cost value for these personnel because their length of deployment and military rank data were not readily available. PRO RATA SHARE OF PROCUREMENT COSTS FOR MOST USED WEAPON SYSTEMS ------------------------------------------------------------ Letter :4 To estimate the pro rata share of the original procurement costs of weapon systems used most often by the active component in counterdrug activities, we used the total flying hours or steaming days these systems were used for counterdrug activities. We identified three types of aircraft and one type of ship for this analysis--the Air Force E-3 aircraft, Army UH-60 helicopter, and Navy P-3 aircraft and Perry class frigate. For the four systems, we obtained their original procurement costs and their original expected lives (in flying hours or steaming days). Using these factors, we computed a cost per hour/day that could be applied to the time flown/steamed for counterdrug activities. Using the methodology we developed, we calculated that about $150 million of the procurement costs for the four systems could be allocated to counterdrug activities for fiscal years 1994-97.\8 As shown in table 3, most of these costs were for the Perry class frigate due to the number of days steamed in support of counterdrug activities. Table 3 Pro Rata Share of Procurement Costs for Most Used Weapon Systems (Dollars in millions) Fiscal year ------------------------------ System 1994 1995 1996 1997 Total ------------------------------ ------ ------ ------ ------ ====== E-3 $3.1 $1.2 $1.6 $1.5 $7.4 UH-60 1.8 2.1 3.2 5.4 12.5 P-3 3.2 4.4 5.4 4.4 17.4 FFG (Perry Class Frigate) 37.7 33.8 23.2 19.0 113.7 ====================================================================== Total $45.8 $41.5 $33.4 $30.3 $151.0 ---------------------------------------------------------------------- Source: Developed by GAO using DOD and service data. The $151 million does not include the cost of research and development and modifications. Service officials advised us that this methodology reflects neither life-cycle nor depreciation costs. -------------------- \8 We estimated the pro rata share of procurement costs through fiscal year 1997 because actual flying hour and steaming day data were not yet available for fiscal year 1998. FOREIGN ASSISTANCE PROVIDED UNDER SECTION 506(A)(2) ------------------------------------------------------------ Letter :5 Under section 506(a)(2) of the Foreign Assistance Act, the President is authorized to transfer up to $75 million in defense articles and services each fiscal year. In fiscal years 1994 and 1995, there were no transfers under this authority. In fiscal years 1996 and 1997,\9 a total of $131 million in articles and services were transferred from DOD under this authority. For example, in fiscal year 1996, DOD transferred $75 million in articles and services, such as C-26 aircraft, patrol boats, and radio equipment, to support counterdrug activities in Colombia, Peru, Venezuela, and eastern Caribbean countries. DOD also provides equipment and services to foreign governments and U.S. law enforcement agencies under a number of other authorities. -------------------- \9 As of August 14, 1998, there had been no approved transfers of equipment and services under this act for fiscal year 1998. AGENCY COMMENTS ------------------------------------------------------------ Letter :6 DOD generally concurred with a draft of this report. DOD stated that it established the counterdrug program within the current force structure and that it funds all costs that are incremental and unique to the counterdrug mission in the Central Transfer Account. It also stated that the services continue to program, budget, and fund major acquisition costs, depot level maintenance costs, and force structure requirements, as part of fulfilling its overall mission. It believes that section 506(a)(2) costs should be included in the value of the counterdrug program but did not believe that O&S and acquisition costs should be included because these are service-specific costs that are intrinsically incurred by each service. DOD stated that we did not estimate the cost of active duty military personnel salaries or excess defense articles under 10 U.S.C. 2576(a). We agree with DOD and specifically state in the report that DOD does not include depot-level maintenance and other O&S costs in its counterdrug budget because they pertain to existing force structure and would be incurred regardless of the type of operations conducted. We also agree and state that weapon systems used for counterdrug activities were purchased to support the overall mission of DOD. We recognize, as DOD pointed out, that most O&S and weapon systems costs would be incurred regardless of the counterdrug mission. We included active component military personnel costs associated with weapon systems used for counterdrug activities, but did not include these costs for personnel deployed to a counterdrug activity that were not associated with a weapon system because data were not readily available. Although we do not specifically mention defense articles under 10 U.S.C. 2576(a), we state in the report that DOD provides equipment and services to foreign governments under other authorities. We believe, and DOD recognizes, that our cost estimates can be used as a reference in estimating DOD's support for counterdrug activities. SCOPE AND METHODOLOGY ------------------------------------------------------------ Letter :7 To estimate the O&S costs not captured in the DOD counterdrug budget, we first obtained data on the weapon systems, operating hours, and costs directly associated with counterdrug activities. These data were reported by the services to the Office of the Secretary of Defense for fiscal years 1994-98. In addition, we obtained total O&S costs, primarily reported in the VAMOSC database, for these systems. Although each service reports VAMOSC data differently, we attempted to gather and analyze the data in the same manner for all services. To the extent possible, where data were not available in VAMOSC, we worked with the services to obtain information from other service sources. For example, we calculated Navy installation support costs based on average cost factors and personnel data the Navy provided. We also calculated Army mission personnel costs for aviation systems by obtaining average personnel costs and other personnel data from the Army. Once we obtained the O&S data, we estimated a total O&S cost per hour and applied this cost rate to the number of hours flown/days steamed in support of counterdrug activities. We subtracted the DOD-reported counterdrug costs from our computed cost to avoid double counting. We were unable to obtain some data, such as Army base operating support costs. We interviewed officials and obtained documents at the Army Cost and Economic Analysis Center, the Navy Center for Cost Analysis, the Air Force Cost Analysis Center, the Office of the DOD Coordinator for Drug Enforcement Policy and Support, and the Army, the Navy, and the Air Force counterdrug offices. We did not independently verify the data provided to us. To estimate a pro rata share of the original procurement costs for systems most often used in counterdrug activities, we developed a methodology in consultation with the services. We obtained procurement costs and useful life data from the service program offices for each of the systems in our analysis. We did not independently verify the data provided to us. To obtain information on the value of section 506(a)(2) assistance for counterdrug purposes, we interviewed officials and examined documents at the Defense Security Assistance Agency, which develops, implements, and monitors security assistance plans and programs. We performed our review between March 1998 and August 1998 in accordance with generally accepted government auditing standards. ---------------------------------------------------------- Letter :7.1 We are providing copies of this report to the Secretaries of Defense, the Army, the Navy, and the Air Force. This report will also be made available to others on request. If you or your staff have any questions about this report, please contact me at (202) 512-3504. Robert Pelletier, Lisa Quinn, and Joe Kirschbaum prepared this report. Richard Davis Director, National Security Analysis (See figure in printed edition.)APPENDIX I COMMENTS FROM THE DEPARTMENT OF DEFENSE ============================================================== Letter (See figure in printed edition.) *** End of document. ***